Drug intelligence / Profile preview

Anabasan

Development stage: Unknown
Lead developer: LIMOR de Colombia
Modality: Vaccines & Immunotherapeutics
Administration: Subcutaneous

Overview

**Anabasan** is a LIMOR veterinary **live-attenuated trivalent vaccine** for prevention of bovine hemoparasitic disease caused by *Anaplasma marginale*, *Babesia bigemina*, and *Babesia bovis*. It is an approved cattle vaccine intended to induce protective immunity against bovine anaplasmosis and babesiosis. ([limorcolombia.com](https://limorcolombia.com/anabasan/))

Brand names: Anabasan

Beyond the preview

Go deeper on Anabasan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anabasan.

Explore the full profile